Applied Materials reported fiscal fourth-quarter earnings that missed analysts’ expectations, sending shares lower after the ...
Michael Burry's Scion Asset Management ramped up its bets on three Chinese tech giants but also hedged its positions.
The prospect of another US-China trade war on Donald Trump’s return to the White House is largely viewed through the prism of ...
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug from China's LaNova Medicines.Please watch the video at Investors.com - ...